PHASE-I CLINICAL-TRIAL OF SODIUM CYANATE IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA

被引:6
作者
HERRERAORNELAS, L
PETRELLI, NJ
MADAJEWICZ, S
MITTELMAN, A
ALLFREY, VG
机构
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT CLIN PHARMACOL & THERAPEUT,BUFFALO,NY 14263
[2] ROCKEFELLER UNIV,NEW YORK,NY 10021
关键词
D O I
10.1159/000226038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:236 / 241
页数:6
相关论文
共 17 条
[1]  
ALLFREY VG, 1977, CANCER-AM CANCER SOC, V40, P2692, DOI 10.1002/1097-0142(197711)40:5+<2692::AID-CNCR2820400942>3.0.CO
[2]  
2-7
[3]  
ALLFREY VG, 1982, FALK S, V31, P385
[4]   ACTIONS OF CYANATE [J].
BIRCH, KM ;
SCHUTZ, F .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1946, 1 (03) :186-193
[5]  
BOFFA LC, 1981, CANCER RES, V41, P60
[6]  
CERAMI A, 1973, J PHARMACOL EXP THER, V185, P653
[7]   POTASSIUM CYANATE AS AN INHIBITOR OF SICKLING OF ERYTHROCYTES IN-VITRO (UREA/HEMOGLOBIN S/CARBAMYLATED VALINE) [J].
CERAMI, A ;
MANNING, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (06) :1180-+
[8]  
DANOPOULOS ED, 1974, LANCET, V1, P115
[9]  
DANOPOULOS ED, 1974, LANCET, V1, P132
[10]  
DUFOUR M, 1984, CANCER CHEMOTH PHARM, V12, P94